156
Participants
Start Date
April 2, 2018
Primary Completion Date
May 31, 2031
Study Completion Date
May 31, 2031
Dexamethasone
Infusion; Intravenous (IV), or Tablet; Oral
Daratumumab
Injection; Subcutaneous (preferred), Infusion; Intravenous (IV)
Venetoclax
Tablet; Oral
Bortezomib
Injection; Subcutaneous (preferred), Infusion; Intravenous (IV)
The Kinghorn Cancer Centre /ID# 165431, Darlinghurst
Rigshospitalet /ID# 164420, Copenhagen Ø
St George Hospital /ID# 171063, Kogarah
Peter MacCallum Cancer Ctr /ID# 164742, Melbourne
St Vincent's Hospital Melbourne /ID# 165853, Fitzroy Melbourne
Eastern Health /ID# 165850, Box Hill
Duplicate_Royal Adelaide Hospital /ID# 171060, Adelaide
Odense University Hospital /ID# 164417, Odense
Duplicate_Royal Perth Hospital /ID# 224895, Perth
Sygehus Lillebalt, Vejle /ID# 164418, Vejle
Duplicate_Aarhus University Hospital /ID# 164509, Aarhus N
Duplicate_Roswell Park Comprehensive Cancer Center /ID# 169615, Buffalo
Atrium Health Carolinas Medical Center /ID# 164948, Charlotte
Winship Cancer Institute of Emory University /ID# 165427, Atlanta
CHRU Tours - Hopital Bretonneau /ID# 164795, Tours
Centre Hospitalier Universitaire de Nantes, Hotel Dieu -HME /ID# 164767, Nantes
University Hospital Cologne /ID# 166037, Cologne
Duplicate_AP-HP - Hopital Saint-Louis /ID# 224758, Paris
Universitaetsklinikum Freiburg /ID# 166036, Freiburg im Breisgau
Univ of Colorado Cancer Center /ID# 167331, Aurora
CHU Poitiers - La miletrie /ID# 164806, Poitiers
CHU Limoges - Dupuytren 1 /ID# 224759, Limoges
Institut Gustave Roussy /ID# 164807, Villejuif
Oregon Health and Science University /ID# 166822, Portland
University of Washington /ID# 164884, Seattle
Moffitt Cancer Center /ID# 169614, Tampa
The University of Chicago Medical Center /ID# 165429, Chicago
Beth Israel Deaconess Medical Center /ID# 210904, Boston
Dana-Farber Cancer Institute /ID# 166886, Boston
Hackensack Univ Med Ctr /ID# 225111, Hackensack
Weill Cornell Medicine/NYP /ID# 167605, New York
Duke Cancer Center /ID# 165104, Durham
Duplicate_Wake Forest Baptist Health /ID# 224447, Winston-Salem
Arthur J. E. Child Comprehensive Cancer Centre /ID# 167822, Calgary
Cross Cancer Institute /ID# 203114, Edmonton
Disc_Royal Victoria Hospital / McGill University Health Centre /ID# 167824, Montreal
Nagoya City University Hospital /ID# 225273, Nagoya
Kameda General Hospital /ID# 225246, Kamogawa-shi
Duplicate_Matsuyama Red Cross Hospital /ID# 225196, Matsuyama
Gifu Municipal Hospital /ID# 240381, Gifu
Lead Sponsor
Janssen Research & Development, LLC
INDUSTRY
AbbVie
INDUSTRY